Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 31INDUSTRY 8NIH 5NETWORK 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 179Leukemia 162Lymphoma 116Lung Neoplasms 107Carcinoma, Non-Small-Cell Lung 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Central Nervous System Neoplasms 84Sarcoma 82Prostatic Neoplasms 81Ovarian Neoplasms 76Colorectal Neoplasms 71Head and Neck Neoplasms 70Leukemia, Myeloid, Acute 60Squamous Cell Carcinoma of Head and Neck 54Rectal Neoplasms 54Neuroblastoma 52Colonic Neoplasms 52Multiple Myeloma 51Uterine Cervical Neoplasms 47Brain Neoplasms 46Lymphoma, Large B-Cell, Diffuse 45Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Ovarian Epithelial 41Burkitt Lymphoma 41Astrocytoma 40Glioblastoma 39Fallopian Tube Neoplasms 39Neoplasm Metastasis 38Congenital Abnormalities 37Lymphoma, Follicular 36

Interventions

Taxes 2Paclitaxel 2Carboplatin 2Ramucirumab 1Prednisone 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NETWORK × Thymoma × Clear all
NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
21 enrolled 17 charts
Thoracic

Thymoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
Thoracic

Thymoma

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Eastern Cooperative Oncology Group

Phase 2 Completed
38 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡